论文信息 - 304 Capecitabine plus irinotecan (XELIRI) in first line metastatic colorectal cancer (MCRC): update on a phase II trial - 字舞流文

304 Capecitabine plus irinotecan (XELIRI) in first line metastatic colorectal cancer (MCRC): update on a phase II trial

E. Lin | S. Eckhardt | W. Keiser | Y. Patt | F. Lee | G. Justice | W. Miller | J. Leibmann | D. Diamandidis | M. Javie